These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28209555)

  • 1. Detection of soluble ERBB2 in breast cancer cell lysates using a combined label-free/fluorescence platform based on Bloch surface waves.
    Sinibaldi A; Sampaoli C; Danz N; Munzert P; Sibilio L; Sonntag F; Occhicone A; Falvo E; Tremante E; Giacomini P; Michelotti F
    Biosens Bioelectron; 2017 Jun; 92():125-130. PubMed ID: 28209555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloch Surface Waves Biosensors for High Sensitivity Detection of Soluble ERBB2 in a Complex Biological Environment.
    Sinibaldi A; Sampaoli C; Danz N; Munzert P; Sonntag F; Centola F; Occhicone A; Tremante E; Giacomini P; Michelotti F
    Biosensors (Basel); 2017 Aug; 7(3):. PubMed ID: 28817097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassay engineering: a combined label-free and fluorescence approach to optimize HER2 detection in complex biological media.
    Sinibaldi A; Doricchi A; Pileri T; Allegretti M; Danz N; Munzert P; Giordani E; Giacomini P; Michelotti F
    Anal Bioanal Chem; 2020 May; 412(14):3509-3517. PubMed ID: 32300843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amperometric magnetoimmunosensor for ErbB2 breast cancer biomarker determination in human serum, cell lysates and intact breast cancer cells.
    Eletxigerra U; Martinez-Perdiguero J; Merino S; Barderas R; Torrente-Rodríguez RM; Villalonga R; Pingarrón JM; Campuzano S
    Biosens Bioelectron; 2015 Aug; 70():34-41. PubMed ID: 25791465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct competitive assay for HER2 detection in human plasma using Bloch surface wave-based biosensors.
    Pileri T; Sinibaldi A; Occhicone A; Danz N; Giordani E; Allegretti M; Sonntag F; Munzert P; Giacomini P; Michelotti F
    Anal Biochem; 2024 Jan; 684():115374. PubMed ID: 37914005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance immunosensor for ErbB2 breast cancer biomarker determination in human serum and raw cancer cell lysates.
    Eletxigerra U; Martinez-Perdiguero J; Barderas R; Pingarrón JM; Campuzano S; Merino S
    Anal Chim Acta; 2016 Jan; 905():156-62. PubMed ID: 26755150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design rules for combined label-free and fluorescence Bloch surface wave biosensors.
    Michelotti F; Rizzo R; Sinibaldi A; Munzert P; Wächter C; Danz N
    Opt Lett; 2017 Jul; 42(14):2798-2801. PubMed ID: 28708172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optofluidic metasurface for lateral flow-through detection of breast cancer biomarker.
    Wang Y; Ali MA; Chow EKC; Dong L; Lu M
    Biosens Bioelectron; 2018 Jun; 107():224-229. PubMed ID: 29475186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-Free Monitoring of Human IgG/Anti-IgG Recognition Using Bloch Surface Waves on 1D Photonic Crystals.
    Sinibaldi A; Occhicone A; Munzert P; Danz N; Sonntag F; Michelotti F
    Biosensors (Basel); 2018 Jul; 8(3):. PubMed ID: 30044392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
    Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
    Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angularly resolved ellipsometric optical biosensing by means of Bloch surface waves.
    Sinibaldi A; Anopchenko A; Rizzo R; Danz N; Munzert P; Rivolo P; Frascella F; Ricciardi S; Michelotti F
    Anal Bioanal Chem; 2015 May; 407(14):3965-74. PubMed ID: 25782873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed specific label-free detection of NCI-H358 lung cancer cell line lysates with silicon based photonic crystal microcavity biosensors.
    Chakravarty S; Lai WC; Zou Y; Drabkin HA; Gemmill RM; Simon GR; Chin SH; Chen RT
    Biosens Bioelectron; 2013 May; 43():50-5. PubMed ID: 23274197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A versatile quantitation platform based on platinum nanoparticles incorporated volumetric bar-chart chip for highly sensitive assays.
    Wang Y; Zhu G; Qi W; Li Y; Song Y
    Biosens Bioelectron; 2016 Nov; 85():777-784. PubMed ID: 27285358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.
    Ni R; Mulligan AM; Have C; O'Malley FP
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):316-24. PubMed ID: 17721278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies.
    Singer CF; Köstler WJ; Hudelist G
    Biochim Biophys Acta; 2008 Dec; 1786(2):105-13. PubMed ID: 18375208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A label-free electrochemical affisensor for cancer marker detection: The case of HER2.
    Ravalli A; da Rocha CG; Yamanaka H; Marrazza G
    Bioelectrochemistry; 2015 Dec; 106(Pt B):268-75. PubMed ID: 26260578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tid1, CHIP and ErbB2 interactions and their prognostic implications for breast cancer patients.
    Jan CI; Yu CC; Hung MC; Harn HJ; Nieh S; Lee HS; Lou MA; Wu YC; Chen CY; Huang CY; Chen FN; Lo JF
    J Pathol; 2011 Nov; 225(3):424-37. PubMed ID: 21710689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low fouling alkylimidazolium modified surfaces for the detection of HER2 in breast cancer cell lysates [corrected].
    Aubé A; Campbell S; Schmitzer AR; Claing A; Masson JF
    Analyst; 2017 Jun; 142(13):2343-2353. PubMed ID: 28560368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
    Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
    Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.